| Nr. | Year OPEN | Title | users say> | rate good | rate bad | no link | Citation |
NicotinePremedication and perioperative medicineBupropionVareniclineRimonabantEndothelinAnalgesics agents and analgetic effectsThirdhand smoke| 1 | 2003 | Tobacco cessation in primary care: maximizing intervention strategies. | 
| + | - | nl | Clin Med Res 1(3):201-16 (2003) Anczak JD |
| 2 | 2000 | Pharmacotherapy of smoking cessation. | 
| + | - | nl | Arch Fam Med 9(3):270-81 (2000) |
| 3 | 2008 | Update on pharmacologic and nonpharmacologic therapies for smoking cessation. | 
| + | - | nl | Can Fam Physician 54(7):994-9 (2008) |
| 4 | 1988 | Tobacco and health: a review of the history and suggestions for public health policy. | 
| + | - | nl | Public Health Rep 103(1):8-18 (1988) |
| 5 | 2007 | Pharmacological and chemical effects of cigarette additives. | 
| + | - | nl | Am J Public Health 97(11):1981-91 (2007) |
| 6 | 2006 | Perioperative abstinence from cigarettes: physiologic and clinical consequences. | 
| + | - | nl | Anesthesiology 104(2):356-67 (2006) |
| 7 | 2008 | Nicotine addiction. | 
| + | - | nl | Am J Psychiatry 165(9):1089-92 (2008) Berrettini W |
| 8 | 2005 | Pharmacotherapy and pharmacogenetics of nicotine dependence. | 
| + | - | nl | Am J Psychiatry 162(8):1441-51 (2005) |
| 9 | 1996 | Molecular and cellular aspects of nicotine abuse. | 
| + | - | nl | Neuron 16(5):905-8 (1996) |
| 10 | 2006 | Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent. | 
| + | - | nl | CNS Drug Rev 12(3-4):178-207 (2006) |
| 11 | 2008 | Tobacco smoking cessation management: integrating varenicline in current practice. | 
| + | - | nl | Vasc Health Risk Manag 4(4):837-45 (2008) |
| 12 | 2007 | Rimonabant for treating tobacco dependence. | 
| + | - | nl | Vasc Health Risk Manag 3(3):307-11 (2007) |
| 13 | 2005 | Metabolism and disposition kinetics of nicotine. | 
| + | - | nl | Pharmacol Rev 57(1):79-115 (2005) |
| 14 | 2009 | Varenicline in the management of smoking cessation: a single technology appraisal. | 
| + | - | nl | Health Technol Assess 13 Suppl 2(-):9-13 (2009) |
| 15 | 2007 | In the clinic. Smoking cessation. | 
| + | - | nl | Ann Intern Med 146(3):ITC2-1-ICT2-16 (2007) |
| 16 | 2006 | Systematic review: smoking cessation intervention strategies for adults and adults in special populations. | 
| + | - | nl | Ann Intern Med 145(11):845-56 (2006) |
| 17 | 2008 | Smoking-induced metabolic disorders: a review. | 
| + | - | nl | Diabetes Metab 34(4 Pt 1):307-14 (2008) |
| 18 | 2007 | Smoking cessation in patients with respiratory diseases: a high priority, integral component of therapy. | 
| + | - | nl | Eur Respir J 29(2):390-417 (2007) |
| 19 | 2004 | The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation. | 
| + | - | nl | Eur Respir J 23(3):464-76 (2004) |
| 20 | 2001 | Smoking-related interstitial lung diseases: a concise review. | 
| + | - | nl | Eur Respir J 17(1):122-32 (2001) |
| 21 | 2002 | Medications for smoking cessation. | 
| + | - | nl | West J Med 176(2):131-5 (2002) |
| 22 | 2008 | Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials. | 
| + | - | nl | CMAJ 179(2):135-44 (2008) Eisenberg MJ |
| 23 | 2007 | Treatment of tobacco dependence: integrating recent progress into practice. | 
| + | - | nl | CMAJ 177(11):1373-80 (2007) |
| 24 | 2010 | Cognitive effects of nicotine: genetic moderators. | 
| + | - | nl | Addict Biol 15(3):250-65 (2010) |
| 25 | 2003 | Treating nicotine addiction. | 
| + | - | nl | BMJ 327(7428):1394-5 (2003) |
| 26 | 2003 | Smoking cessation. | 
| + | - | nl | Respir Care 48(12):1238-54; discussion 1254-6 (2003) |
| 27 | 2008 | Treatment of tobacco dependence. | 
| + | - | nl | Mayo Clin Proc 83(4):479-83; quiz 483-4 (2008) |
| 28 | 2010 | Smoking cessation. | 
| + | - | nl | Chest 137(2):428-35 (2010) |
| 29 | 2007 | Systemic effects of smoking. | 
| + | - | nl | Chest 131(5):1557-66 (2007) |
| 30 | 2010 | Up-regulation of endothelin receptors induced by cigarette smoke--involvement of MAPK in vascular and airway hyper-reactivity. | 
| + | - | nl | ScientificWorldJournal 10(-):2157-66 (2010) |
| 31 | 2011 | Smoking-induced nociception. | 
| + | - | nl | Pain Physician 14(1):E1-4 (2011) |
| 32 | 2010 | Nicotine addiction. | 
| + | - | nl | N Engl J Med 362(24):2295-303 (2010) |
| 33 | 2011 | Treatment of tobacco dependence. | 
| + | - | nl | Dtsch Arztebl Int 108(33):555-64 (2011) |
| 34 | 2002 | The clinical effectiveness and cost-effectiveness of bupropion and nicotine replacement therapy for smoking cessation: a systematic review and economic evaluation. | 
| + | - | nl | Health Technol Assess 6(16):1-245 (2002) |
| 35 | 2010 | Relapse prevention in UK Stop Smoking Services: current practice, systematic reviews of effectiveness and cost-effectiveness analysis. | 
| + | - | nl | Health Technol Assess 14(49):1-152, iii-iv (2010) |
| 36 | 2005 | Pharmacokinetics and metabolism of nicotine. | 
| + | - | nl | Pharmacol Rep 57(2):143-53 (2005) |
| 37 | 2009 | Nicotine dependence - human and animal studies, current pharmacotherapies and future perspectives. | 
| + | - | nl | Pharmacol Rep 61(6):957-65 (2009) |
| 38 | 2011 | Thirdhand tobacco smoke: emerging evidence and arguments for a multidisciplinary research agenda. | 
| + | - | nl | Environ Health Perspect 119(9):1218-26 (2011) |